Some pharmacies still not dispensing "Clexane" on prescription; Health Fund insists it's their obligation
Despite the availability of the blood-thinning medication "Clexane" for prescription pickup in pharmacies since July 1, 2026, some citizens report being denied the drug. These individuals were informed by certain pharmacies that they are still awaiting official notification from the Health Fund before dispensing the medication. "Clexane" is primarily used by pregnant women. The Health Insurance Fund (FZO) has stated that dispensing this medication on prescription is a mandatory obligation for pharmacies. The issue was reported by TV "24" and subsequently published by "Sloboden Pecat". The delay in dispensing "Clexane" on prescription raises concerns about timely access to essential medication for patients, particularly pregnant women who rely on it.
The reported discrepancy in dispensing "Clexane" highlights potential inefficiencies in the communication and implementation of new pharmaceutical regulations between the Health Insurance Fund and individual pharmacies. While the Health Fund asserts its obligation, the pharmacies' hesitation suggests a breakdown in the information flow or a need for clearer procedural guidance. This situation could impact patient access to critical medication, underscoring the importance of robust administrative processes to ensure seamless healthcare delivery. Future policy implementations should prioritize comprehensive training and immediate dissemination of directives to all healthcare providers to prevent such access delays.
AI-generated to prompt reflection — not editorial opinion, not advice, not a statement of fact. How this works.